p53 mutations and clinical-pathological variables
| p53 mutations | ||||
|---|---|---|---|---|
| Variables | − | + | OR | 95% CI |
| OR, odds ratio; 95% CI, 95% confidence interval. | ||||
| Sex | ||||
| Female | 54 | 3 | 0.48 | 0.11 to 2.11 |
| Male | 43 | 5 | ||
| Lauren histotype | ||||
| Diffuse | 69 | 5 | 0.68 | 0.15 to 3.02 |
| Intestinal | 28 | 3 | ||
| Tumour site | ||||
| Antrum | 61 | 2 | 0.20 | 0.04 to 1.03 |
| Corpus | 24 | 2 | 1.01 | 0.19 to 3.37 |
| Cardia | 12 | 4 | 7.09 | 1.56 to 32.11 |
| Gastritis | ||||
| Non-atrophic | 68 | 6 | 1.28 | 0.24 to 6.67 |
| Atrophic/metaplastic | 29 | 2 | ||
| Tumour stage | ||||
| Stage I | 27 | 1 | 0.37 | 0.04 to 3.17 |
| Stages II–III–VI | 70 | 7 | ||